Join Abzena & OncoDesign Services for a half-day workshop on Thursday, 25th April in Cambridge, UK focused on strategies for streamlining large molecule drug programs to IND and beyond.
Hear from industry experts from NGT Biopharma Consultants, Trio Pharmaceuticals, OncoDesign Services and Abzena, as they share insights and real-world case studies that cover regulatory, design and developability considerations that drug developers should take into account when bridging a molecule from discovery to the clinic.

Lunch, poster presentations and a networking reception will be included, along with an optional facility tour of Abzena’s Cambridge facility. The workshop will be held in The Petersfield Lecture Theatre in the Cambridge Building on the Babraham Research Campus. *Registration deadline for our event is Tuesday, April 23rd.

What You’ll Learn:

-Gain insights on preclinical processes for of new therapeutic compounds

-Technical expectations & regulatory process for a successful CTA/IND application.

-De-risking is a continual process that starts long before you’ve identified a lead candidate

-Nonclinical science (g., toxicology & pharmacology) requirements for transitioning from candidate selection into preclinical development and ultimately first in human (FIH) studies.

-How an integrated early development strategy can reduce development times, cost and risk

-Global regulatory and quality expectations.

-How to leverage the ecosystem to enable successful drug development

Agenda for Thursday, 25th April
12:00 to 13:30 pm – Lunch & Optional Facility Tour of Abzena’s site
13:30 pm to 13:45 pm – Opening Address by Dr Campbell Bunce, CSO at Abzena
13:45 pm to 14:15 pm – “Navigating the Regulatory Landscape to Large Molecule CTA/IND Applications” by NGT Biopharma Consultants
14: 15 pm to 14:45 pm – “Integrated Approach for Streamlining Development” with Drive Bio
15:00 pm to 15:30 pm – “Perspective on evaluating different therapeutic strategies to demonstrate proof of concept with preclinical in vitro and in vivo studies” with OncoDesign Services
15:30 pm to 16:00 pm – “Principles and Practice of derisking lead drug candidate discovery, design and selection” with Abzena
16:00 pm to 16:45 pm – “Antibody Program Case Study” with Trio Pharmaceuticals
16:45 pm- 18:00 pm – Networking Reception with Scientific Posters, Beverages & Canapes*Registration deadline for our event is Tuesday, April 23rd.